Meaning Afoxolaner's chewable tablets
The global market for Afoxolaner Chewable Tablets is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Afoxolaner Chewable Tablets market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Afoxolaner Chewable Tablets market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Afoxolaner Chewable Tablets market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Afoxolaner Chewable Tablets market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Afoxolaner Chewable Tablets players cover Merial Toulouse and Boehringer Ingelheim.. etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Afoxolaner Chewable Tablets market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Afoxolaner Chewable Tablets market, with both quantitative and qualitative data, to help readers understand how the Afoxolaner Chewable Tablets market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Box.
Market Segmentation:
The study segments the Afoxolaner Chewable Tablets market and forecasts the market size by Purity (Afoxolaner Chewable Tablets and Afoxolaner and Milbemycin Oxime Chewable Tablets,), by Symptom (Tick Infection in Dogs, Gastrointestinal Nematode Infection in Dogs and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by purity
Afoxolaner Chewable Tablets
Afoxolaner and Milbemycin Oxime Chewable Tablets
Segmentation by symptom
Tick Infection in Dogs
Gastrointestinal Nematode Infection in Dogs
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Merial Toulouse
Boehringer Ingelheim
Chapter Introduction
Chapter 1: Scope of Afoxolaner Chewable Tablets, Research Methodology, etc.
Chapter 2: Executive Summary, global Afoxolaner Chewable Tablets market size (sales and revenue) and CAGR, Afoxolaner Chewable Tablets market size by region, by purity, by symptom, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Afoxolaner Chewable Tablets sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Afoxolaner Chewable Tablets sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by purity, and purity.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Afoxolaner Chewable Tablets market size forecast by region, by country, by purity, and symptom.
Chapter 13: Comprehensive company profiles of the leading players, including Merial Toulouse and Boehringer Ingelheim etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Afoxolaner Chewable Tablets Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Afoxolaner Chewable Tablets by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Afoxolaner Chewable Tablets by Country/Region, 2017, 2022 & 2028
2.2 Afoxolaner Chewable Tablets Segment by Purity
2.2.1 Afoxolaner Chewable Tablets
2.2.2 Afoxolaner and Milbemycin Oxime Chewable Tablets
2.3 Afoxolaner Chewable Tablets Sales by Purity
2.3.1 Global Afoxolaner Chewable Tablets Sales Market Share by Purity (2017-2022)
2.3.2 Global Afoxolaner Chewable Tablets Revenue and Market Share by Purity (2017-2022)
2.3.3 Global Afoxolaner Chewable Tablets Sale Price by Purity (2017-2022)
2.4 Afoxolaner Chewable Tablets Segment by Symptom
2.4.1 Tick Infection in Dogs
2.4.2 Gastrointestinal Nematode Infection in Dogs
2.4.3 Other
2.5 Afoxolaner Chewable Tablets Sales by Symptom
2.5.1 Global Afoxolaner Chewable Tablets Sale Market Share by Symptom (2017-2022)
2.5.2 Global Afoxolaner Chewable Tablets Revenue and Market Share by Symptom (2017-2022)
2.5.3 Global Afoxolaner Chewable Tablets Sale Price by Symptom (2017-2022)
3 Global Afoxolaner Chewable Tablets by Company
3.1 Global Afoxolaner Chewable Tablets Breakdown Data by Company
3.1.1 Global Afoxolaner Chewable Tablets Annual Sales by Company (2020-2022)
3.1.2 Global Afoxolaner Chewable Tablets Sales Market Share by Company (2020-2022)
3.2 Global Afoxolaner Chewable Tablets Annual Revenue by Company (2020-2022)
3.2.1 Global Afoxolaner Chewable Tablets Revenue by Company (2020-2022)
3.2.2 Global Afoxolaner Chewable Tablets Revenue Market Share by Company (2020-2022)
3.3 Global Afoxolaner Chewable Tablets Sale Price by Company
3.4 Key Manufacturers Afoxolaner Chewable Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Afoxolaner Chewable Tablets Product Location Distribution
3.4.2 Players Afoxolaner Chewable Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Afoxolaner Chewable Tablets by Geographic Region
4.1 World Historic Afoxolaner Chewable Tablets Market Size by Geographic Region (2017-2022)
4.1.1 Global Afoxolaner Chewable Tablets Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Afoxolaner Chewable Tablets Annual Revenue by Geographic Region
4.2 World Historic Afoxolaner Chewable Tablets Market Size by Country/Region (2017-2022)
4.2.1 Global Afoxolaner Chewable Tablets Annual Sales by Country/Region (2017-2022)
4.2.2 Global Afoxolaner Chewable Tablets Annual Revenue by Country/Region
4.3 Americas Afoxolaner Chewable Tablets Sales Growth
4.4 APAC Afoxolaner Chewable Tablets Sales Growth
4.5 Europe Afoxolaner Chewable Tablets Sales Growth
4.6 Middle East & Africa Afoxolaner Chewable Tablets Sales Growth
5 Americas
5.1 Americas Afoxolaner Chewable Tablets Sales by Country
5.1.1 Americas Afoxolaner Chewable Tablets Sales by Country (2017-2022)
5.1.2 Americas Afoxolaner Chewable Tablets Revenue by Country (2017-2022)
5.2 Americas Afoxolaner Chewable Tablets Sales by Purity
5.3 Americas Afoxolaner Chewable Tablets Sales by Symptom
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Afoxolaner Chewable Tablets Sales by Region
6.1.1 APAC Afoxolaner Chewable Tablets Sales by Region (2017-2022)
6.1.2 APAC Afoxolaner Chewable Tablets Revenue by Region (2017-2022)
6.2 APAC Afoxolaner Chewable Tablets Sales by Purity
6.3 APAC Afoxolaner Chewable Tablets Sales by Symptom
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Afoxolaner Chewable Tablets by Country
7.1.1 Europe Afoxolaner Chewable Tablets Sales by Country (2017-2022)
7.1.2 Europe Afoxolaner Chewable Tablets Revenue by Country (2017-2022)
7.2 Europe Afoxolaner Chewable Tablets Sales by Purity
7.3 Europe Afoxolaner Chewable Tablets Sales by Symptom
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Afoxolaner Chewable Tablets by Country
8.1.1 Middle East & Africa Afoxolaner Chewable Tablets Sales by Country (2017-2022)
8.1.2 Middle East & Africa Afoxolaner Chewable Tablets Revenue by Country (2017-2022)
8.2 Middle East & Africa Afoxolaner Chewable Tablets Sales by Purity
8.3 Middle East & Africa Afoxolaner Chewable Tablets Sales by Symptom
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Afoxolaner Chewable Tablets
10.3 Manufacturing Process Analysis of Afoxolaner Chewable Tablets
10.4 Industry Chain Structure of Afoxolaner Chewable Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Afoxolaner Chewable Tablets Distributors
11.3 Afoxolaner Chewable Tablets Customer
12 World Forecast Review for Afoxolaner Chewable Tablets by Geographic Region
12.1 Global Afoxolaner Chewable Tablets Market Size Forecast by Region
12.1.1 Global Afoxolaner Chewable Tablets Forecast by Region (2023-2028)
12.1.2 Global Afoxolaner Chewable Tablets Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Afoxolaner Chewable Tablets Forecast by Purity
12.7 Global Afoxolaner Chewable Tablets Forecast by Symptom
13 Key Players Analysis
13.1 Merial Toulouse
13.1.1 Merial Toulouse Company Information
13.1.2 Merial Toulouse Afoxolaner Chewable Tablets Product Offered
13.1.3 Merial Toulouse Afoxolaner Chewable Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merial Toulouse Main Business Overview
13.1.5 Merial Toulouse Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Afoxolaner Chewable Tablets Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Afoxolaner Chewable Tablets Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Afoxolaner Chewable Tablets
Table 4. Major Players of Afoxolaner and Milbemycin Oxime Chewable Tablets
Table 5. Global Afoxolaner Chewable Tablets Sales by Purity (2017-2022) & (Box)
Table 6. Global Afoxolaner Chewable Tablets Sales Market Share by Purity (2017-2022)
Table 7. Global Afoxolaner Chewable Tablets Revenue by Purity (2017-2022) & ($ million)
Table 8. Global Afoxolaner Chewable Tablets Revenue Market Share by Purity (2017-2022)
Table 9. Global Afoxolaner Chewable Tablets Sale Price by Purity (2017-2022) & (US$/Box)
Table 10. Global Afoxolaner Chewable Tablets Sales by Symptom (2017-2022) & (Box)
Table 11. Global Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2022)
Table 12. Global Afoxolaner Chewable Tablets Revenue by Symptom (2017-2022)
Table 13. Global Afoxolaner Chewable Tablets Revenue Market Share by Symptom (2017-2022)
Table 14. Global Afoxolaner Chewable Tablets Sale Price by Symptom (2017-2022) & (US$/Box)
Table 15. Global Afoxolaner Chewable Tablets Sales by Company (2020-2022) & (Box)
Table 16. Global Afoxolaner Chewable Tablets Sales Market Share by Company (2020-2022)
Table 17. Global Afoxolaner Chewable Tablets Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Afoxolaner Chewable Tablets Revenue Market Share by Company (2020-2022)
Table 19. Global Afoxolaner Chewable Tablets Sale Price by Company (2020-2022) & (US$/Box)
Table 20. Key Manufacturers Afoxolaner Chewable Tablets Producing Area Distribution and Sales Area
Table 21. Players Afoxolaner Chewable Tablets Products Offered
Table 22. Afoxolaner Chewable Tablets Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Afoxolaner Chewable Tablets Sales by Geographic Region (2017-2022) & (Box)
Table 26. Global Afoxolaner Chewable Tablets Sales Market Share Geographic Region (2017-2022)
Table 27. Global Afoxolaner Chewable Tablets Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Afoxolaner Chewable Tablets Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Afoxolaner Chewable Tablets Sales by Country/Region (2017-2022) & (Box)
Table 30. Global Afoxolaner Chewable Tablets Sales Market Share by Country/Region (2017-2022)
Table 31. Global Afoxolaner Chewable Tablets Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Afoxolaner Chewable Tablets Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Afoxolaner Chewable Tablets Sales by Country (2017-2022) & (Box)
Table 34. Americas Afoxolaner Chewable Tablets Sales Market Share by Country (2017-2022)
Table 35. Americas Afoxolaner Chewable Tablets Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Afoxolaner Chewable Tablets Revenue Market Share by Country (2017-2022)
Table 37. Americas Afoxolaner Chewable Tablets Sales by Type (2017-2022) & (Box)
Table 38. Americas Afoxolaner Chewable Tablets Sales Market Share by Purity (2017-2022)
Table 39. Americas Afoxolaner Chewable Tablets Sales by Symptom (2017-2022) & (Box)
Table 40. Americas Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2022)
Table 41. APAC Afoxolaner Chewable Tablets Sales by Region (2017-2022) & (Box)
Table 42. APAC Afoxolaner Chewable Tablets Sales Market Share by Region (2017-2022)
Table 43. APAC Afoxolaner Chewable Tablets Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Afoxolaner Chewable Tablets Revenue Market Share by Region (2017-2022)
Table 45. APAC Afoxolaner Chewable Tablets Sales by Purity (2017-2022) & (Box)
Table 46. APAC Afoxolaner Chewable Tablets Sales Market Share by Purity (2017-2022)
Table 47. APAC Afoxolaner Chewable Tablets Sales by Symptom (2017-2022) & (Box)
Table 48. APAC Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2022)
Table 49. Europe Afoxolaner Chewable Tablets Sales by Country (2017-2022) & (Box)
Table 50. Europe Afoxolaner Chewable Tablets Sales Market Share by Country (2017-2022)
Table 51. Europe Afoxolaner Chewable Tablets Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Afoxolaner Chewable Tablets Revenue Market Share by Country (2017-2022)
Table 53. Europe Afoxolaner Chewable Tablets Sales by Type (2017-2022) & (Box)
Table 54. Europe Afoxolaner Chewable Tablets Sales Market Share by Purity (2017-2022)
Table 55. Europe Afoxolaner Chewable Tablets Sales by Symptom (2017-2022) & (Box)
Table 56. Europe Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2022)
Table 57. Middle East & Africa Afoxolaner Chewable Tablets Sales by Country (2017-2022) & (Box)
Table 58. Middle East & Africa Afoxolaner Chewable Tablets Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Afoxolaner Chewable Tablets Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Afoxolaner Chewable Tablets Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Afoxolaner Chewable Tablets Sales by Purity (2017-2022) & (Box)
Table 62. Middle East & Africa Afoxolaner Chewable Tablets Sales Market Share by Purity (2017-2022)
Table 63. Middle East & Africa Afoxolaner Chewable Tablets Sales by Symptom (2017-2022) & (Box)
Table 64. Middle East & Africa Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Afoxolaner Chewable Tablets
Table 66. Key Market Challenges & Risks of Afoxolaner Chewable Tablets
Table 67. Key Industry Trends of Afoxolaner Chewable Tablets
Table 68. Afoxolaner Chewable Tablets Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Afoxolaner Chewable Tablets Distributors List
Table 71. Afoxolaner Chewable Tablets Customer List
Table 72. Global Afoxolaner Chewable Tablets Sales Forecast by Region (2023-2028) & (Box)
Table 73. Global Afoxolaner Chewable Tablets Sales Market Forecast by Region
Table 74. Global Afoxolaner Chewable Tablets Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Afoxolaner Chewable Tablets Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Afoxolaner Chewable Tablets Sales Forecast by Country (2023-2028) & (Box)
Table 77. Americas Afoxolaner Chewable Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Afoxolaner Chewable Tablets Sales Forecast by Region (2023-2028) & (Box)
Table 79. APAC Afoxolaner Chewable Tablets Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Afoxolaner Chewable Tablets Sales Forecast by Country (2023-2028) & (Box)
Table 81. Europe Afoxolaner Chewable Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Afoxolaner Chewable Tablets Sales Forecast by Country (2023-2028) & (Box)
Table 83. Middle East & Africa Afoxolaner Chewable Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Afoxolaner Chewable Tablets Sales Forecast by Purity (2023-2028) & (Box)
Table 85. Global Afoxolaner Chewable Tablets Sales Market Share Forecast by Purity (2023-2028)
Table 86. Global Afoxolaner Chewable Tablets Revenue Forecast by Purity (2023-2028) & ($ Millions)
Table 87. Global Afoxolaner Chewable Tablets Revenue Market Share Forecast by Purity (2023-2028)
Table 88. Global Afoxolaner Chewable Tablets Sales Forecast by Symptom (2023-2028) & (Box)
Table 89. Global Afoxolaner Chewable Tablets Sales Market Share Forecast by Symptom (2023-2028)
Table 90. Global Afoxolaner Chewable Tablets Revenue Forecast by Symptom (2023-2028) & ($ Millions)
Table 91. Global Afoxolaner Chewable Tablets Revenue Market Share Forecast by Symptom (2023-2028)
Table 92. Merial Toulouse Basic Information, Afoxolaner Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Merial Toulouse Afoxolaner Chewable Tablets Product Offered
Table 94. Merial Toulouse Afoxolaner Chewable Tablets Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 95. Merial Toulouse Main Business
Table 96. Merial Toulouse Latest Developments
Table 97. Boehringer Ingelheim Basic Information, Afoxolaner Chewable Tablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Boehringer Ingelheim Afoxolaner Chewable Tablets Product Offered
Table 99. Boehringer Ingelheim Afoxolaner Chewable Tablets Sales (Box), Revenue ($ Million), Price (US$/Box) and Gross Margin (2020-2022)
Table 100. Boehringer Ingelheim Main Business
Table 101. Boehringer Ingelheim Latest Developments
List of Figures
Figure 1. Picture of Afoxolaner Chewable Tablets
Figure 2. Afoxolaner Chewable Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Afoxolaner Chewable Tablets Sales Growth Rate 2017-2028 (Box)
Figure 7. Global Afoxolaner Chewable Tablets Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Afoxolaner Chewable Tablets Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Afoxolaner Chewable Tablets
Figure 10. Product Picture of Afoxolaner and Milbemycin Oxime Chewable Tablets
Figure 11. Global Afoxolaner Chewable Tablets Sales Market Share by Purity in 2021
Figure 12. Global Afoxolaner Chewable Tablets Revenue Market Share by Purity (2017-2022)
Figure 13. Afoxolaner Chewable Tablets Consumed in Tick Infection in Dogs
Figure 14. Global Afoxolaner Chewable Tablets Market: Tick Infection in Dogs (2017-2022) & (Box)
Figure 15. Afoxolaner Chewable Tablets Consumed in Gastrointestinal Nematode Infection in Dogs
Figure 16. Global Afoxolaner Chewable Tablets Market: Gastrointestinal Nematode Infection in Dogs (2017-2022) & (Box)
Figure 17. Afoxolaner Chewable Tablets Consumed in Other
Figure 18. Global Afoxolaner Chewable Tablets Market: Other (2017-2022) & (Box)
Figure 19. Global Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2022)
Figure 20. Global Afoxolaner Chewable Tablets Revenue Market Share by Symptom in 2021
Figure 21. Afoxolaner Chewable Tablets Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Afoxolaner Chewable Tablets Revenue Market Share by Company in 2021
Figure 23. Global Afoxolaner Chewable Tablets Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Afoxolaner Chewable Tablets Revenue Market Share by Geographic Region in 2021
Figure 25. Global Afoxolaner Chewable Tablets Sales Market Share by Region (2017-2022)
Figure 26. Global Afoxolaner Chewable Tablets Revenue Market Share by Country/Region in 2021
Figure 27. Americas Afoxolaner Chewable Tablets Sales 2017-2022 (Box)
Figure 28. Americas Afoxolaner Chewable Tablets Revenue 2017-2022 ($ Millions)
Figure 29. APAC Afoxolaner Chewable Tablets Sales 2017-2022 (Box)
Figure 30. APAC Afoxolaner Chewable Tablets Revenue 2017-2022 ($ Millions)
Figure 31. Europe Afoxolaner Chewable Tablets Sales 2017-2022 (Box)
Figure 32. Europe Afoxolaner Chewable Tablets Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Afoxolaner Chewable Tablets Sales 2017-2022 (Box)
Figure 34. Middle East & Africa Afoxolaner Chewable Tablets Revenue 2017-2022 ($ Millions)
Figure 35. Americas Afoxolaner Chewable Tablets Sales Market Share by Country in 2021
Figure 36. Americas Afoxolaner Chewable Tablets Revenue Market Share by Country in 2021
Figure 37. United States Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Afoxolaner Chewable Tablets Sales Market Share by Region in 2021
Figure 42. APAC Afoxolaner Chewable Tablets Revenue Market Share by Regions in 2021
Figure 43. China Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Afoxolaner Chewable Tablets Sales Market Share by Country in 2021
Figure 50. Europe Afoxolaner Chewable Tablets Revenue Market Share by Country in 2021
Figure 51. Germany Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Afoxolaner Chewable Tablets Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Afoxolaner Chewable Tablets Revenue Market Share by Country in 2021
Figure 58. Egypt Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Afoxolaner Chewable Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Afoxolaner Chewable Tablets in 2021
Figure 64. Manufacturing Process Analysis of Afoxolaner Chewable Tablets
Figure 65. Industry Chain Structure of Afoxolaner Chewable Tablets
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles